SUBSCRIBERS

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

Published Wed, Oct 4, 2017 · 09:50 PM

    Singapore

    GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

    On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)